Moderna’s CEO Stéphane Bancel predicts that existing vaccines will be far less effective against Omicron than earlier strains of coronavirus and that it will be months before pharmaceutical companies can mass-produce new variant-specific medicines.
On Tuesday, investors in Asia were startled by his predictions, with equities and stock futures
